Idarucizumab for the treatment of dabigatran-related nephropathy
Keyword(s):
Abstract Anticoagulant-related nephropathy (ARN) is a clinical syndrome of acute kidney injury in patients taking vitamin K antagonists or direct oral anticoagulants. It is associated with increased mortality and there is no specific treatment. We report the case of a 78-year-old man on dabigatran who developed macroscopic haematuria and acute kidney injury 2 weeks after mitral valve repair, reaching a peak creatinine of 415 µmol/L from a normal baseline, which was successfully treated with one course of idarucizumab. This case illustrates the efficacy of an anticoagulant reversal agent for the treatment of ARN.
2018 ◽
Vol 71
(2)
◽
pp. 251-252
◽
Keyword(s):
2019 ◽
Vol 25
(19)
◽
pp. 2149-2157
◽
Keyword(s):
2021 ◽
Vol 77
(18)
◽
pp. 1727
Keyword(s):